WEDGE CAPITAL MANAGEMENT L L P/NC

Position in GILD — Gilead Sciences, Inc.

CIK 1015308 CHARLOTTE, NC

Position in GILD

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$244,720

-$53,531 QoQ

Shares Held

1,937

-9.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,799

of 2,266 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WEDGE CAPITAL MANAGEMENT L L P/NC holds $67,797,573 across 8 Drug Manufacturers - General names. GILD ranks #8 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	134,579	$33,865,459
2	BMY	Bristol Myers Squibb Co	528,057	$30,426,644
3	JNJ	Johnson & Johnson	4,295	$1,090,801
4	LLY	ELI LILLY & Co	764	$916,364
5	MRK	Merck & Co., Inc.	4,873	$626,180
6	PFE	Pfizer Inc	13,423	$323,225
7	AMGN	Amgen Inc	840	$304,180
8	GILD	Gilead Sciences, Inc. This page	1,937	$244,720

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$244,720	1,937	-9.5%	Shares	Sole	2026-07-10
2026-03-31	$298,251	2,140	-99.0%	Shares	Sole	2026-04-13
2025-12-31	$26,721,848	217,711	-4.4%	Shares	Sole	2026-01-14
2025-09-30	$25,290,684	227,844	-20.6%	Shares	Sole	2025-10-10
2025-06-30	$31,811,818	286,929	-4.6%	Shares	Sole	2025-07-11
2025-03-31	$33,695,227	300,716	-4.0%	Shares	Sole	2025-04-14
2024-12-31	$28,932,593	313,225	-21.6%	Shares	Sole	2025-01-15
2024-09-30	$33,505,314	399,634	-18.8%	Shares	Sole	2024-10-11
2021-12-31	$35,746,411	492,307	+12.5%	Shares	Sole	2022-01-24
2021-09-30	$30,562,937	437,551	-7.5%	Shares	Sole	2021-10-14
2021-06-30	$32,569,747	472,985	-1.9%	Shares	Sole	2021-07-14
2021-03-31	$31,159,286	482,118	+13.7%	Shares	Sole	2021-04-12
2020-09-30	$26,784,534	423,873	-4.9%	Shares	Sole	2020-10-08
2020-06-30	$34,309,854	445,930	—	Shares	Sole	2020-07-10
No filing history on record for this holder in this stock.